Posted by Michael Wonder on 29 Jun 2020
Demand for dexamethasone soars after promising findings in UK
27June 2020 - Weekly demand in the U.S. is up more than 600%.
Last week, a study in the U.K. found that dexamethasone, a common steroid, increased survival in severely ill COVID-19 patients who needed help breathing.
Within a few days of that report, weekly demand for dexamethasone increased by over 600% in the U.S., according to data from the health care performance improvement company Vizient. That figure tracks with what's happening globally, as World Health Organization Director-General Tedros Adhanom Ghebreyesus said demand for the drug "surged" in the wake of the U.K. trials.
